Pediatric Neurology
Volume 31, Issue 5 , Pages 371-373, November 2004

A case of X-linked agammaglobulinemia with progressive encephalitis

  • Naohide Shiroma, MD

      Affiliations

    • Department of Pediatrics, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan
    • Corresponding Author InformationCommunications should be addressed to:Dr. Shiroma; Department of Pediatrics; Faculty of Medicine; University of the Ryukyus; 207 Uehara, Nishihara; Okinawa 903-0215, Japan
  • ,
  • Tsuyoshi Omi, MD

      Affiliations

    • Department of Pediatrics, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan
  • ,
  • Hideki Hasegawa, MD, PhD

      Affiliations

    • Department of Pathology, National Institute of Infectious Disease, Tokyo, Japan
  • ,
  • Kazuo Nagashima, MD, PhD

      Affiliations

    • Laboratory of Molecular and Cellular Pathology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
  • ,
  • Takao Ohta, MD, PhD

      Affiliations

    • Department of Pediatrics, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan

Received 18 February 2004; accepted 10 May 2004.

This report describes a case of agammaglobulinemia with progressive encephalitis. The patient was a 6-year-old male who was diagnosed as having Bruton-type agammaglobulinemia at age 6 months. After the diagnosis was made, he received monthly intravenous immunoglobulin replacement with a residual immunoglobulin G level of more than 400 mg/dL. At 5 years of age, he presented with symptoms of mental deterioration and gait disturbance. He had no history of infection of the central nervous system. Brain biopsy revealed CD8-positive T-cell infiltration with cortical damage, but no infectious agents were observed by either immunohistochemistry or virus isolation. Treatment with subcutaneous interferon-α and high-dose intravenous immunoglobulin was begun, and clinical symptoms improved within a month. Hence, patients with agammaglobulinemia should be carefully monitored for complications of the central nervous system even if there is no history of infection.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0887-8994(04)00283-8

doi:10.1016/j.pediatrneurol.2004.05.007

Pediatric Neurology
Volume 31, Issue 5 , Pages 371-373, November 2004